Neoplastic Mesorectal Microfoci (MMF) Following Neoadjuvant Chemoradiotherapy: Clinical and Prognostic Implications

By Ratto Carlo   Ricci Riccardo   Valentini Vincenzo   Castri Federica   Parello Angelo   Gambacorta Maria   Cellini Numa   Vecchio Fabio   Doglietto Giovanni  

Annals of Surgical Oncology, Vol. 13, Iss. 11, 2006-11 ,pp. : 1393-1402

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Significance of Circumferential Resection Margin Following Total Mesorectal Excision and Adjuvant Chemoradiotherapy in Patients with Rectal Cancer

By Baik Seung   Kim Nam   Lee Young   Kim Hoguen   Lee Kang   Sohn Seung   Cho Chang  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 462-469

Springer Publishing Company

Access to resources Recommend Favorite

The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer

By Morse Michael   Nair Smita   Boczkowski David   Tyler Douglas   Hurwitz Herbert   Proia Alan   Clay Timothy   Schlom Jeffrey   Gilboa Eli   Lyerly H.  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 1, 2002-08 ,pp. : 1-6

Humana Press, Inc

Access to resources Recommend Favorite

Breast conservation after neoadjuvant chemotherapy: A prognostic index for clinical decision-making

By Holmes Dennis  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 129-130

Informa Healthcare

Access to resources Recommend Favorite

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

By                  

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 446-452

Spandidos Publications

Access to resources Recommend Favorite